Webcast ImageWebcast
Vaccinex, Inc. at the Ladenburg Thalmann 4th Annual Healthcare Conference (Replay)
10/02/18 at 8:30 a.m. ET
Vaccinex, Inc. at the Ladenburg Thalmann 4th Annual Healthcare Conference
Tuesday, October 2, 2018 8:30 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile
Vaccinex is a clinical-stage biotechnology company engaged in the discovery and development of human therapeutic monoclonal antibodies and other targeted biological therapies. A Vaccinex antibody product is currently in clinical trials for immunotherapy of cancer and to prevent or delay the onset of neurodegenerative Huntington’s disease.
Recent NewsMore »
Upcoming EventsMore »
There are currently no events scheduled.
Data provided by Nasdaq. Minimum 15 minutes delayed.